Because IL-33 mediated protection from C. difficile is accompanied by a reduction of ILC1s and ILC3s and activation of ILC2s (17), it would be important to test if ILC-specific inhibition of Ifng, Ccl5, and Il23r would protect antibiotic-treated mice from CDI. The gene discussed is IL33; the disease is clostridium difficile infection.